Drug intelligence / Profile preview

aceclofenac + paracetamol + domperidone

Development stage
Unknown
Lead developer
Bennet Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

ACIO P DSR is a combination pharmaceutical product developed by Bennet Pharmaceuticals. It contains three active ingredients: **aceclofenac**, a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce pain and inflammation; **paracetamol** (acetaminophen), an analgesic and antipyretic that acts primarily on the central nervous system; and **domperidone**, a dopamine D2 receptor antagonist used as an antiemetic and prokinetic agent. The "DSR" suffix typically indicates that the domperidone component is provided in a sustained-release formulation. This combination is indicated for the management of painful inflammatory conditions (such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis) where there is a risk of NSAID-induced nausea or vomiting.

Brand names
ACIO P DSR
Other names
ACIO-P DSR
02

Targets

DRD2 (Dopamine D2 Receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on aceclofenac + paracetamol + domperidone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aceclofenac + paracetamol + domperidone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call